Links to all GeneRIF Items | 2072 |
PubMed (Gene Name) | Literature evidence |
|---|---|
| 18068852 (ERCC4) | the polymorphism rs3136038 on the promotor region of ERCC4 may contribute to the etiology of lung cancer. |
| 29741112 (ERCC4) | For 11985 A>G polymorphism, lung cancer subjects treated with irinotecan cisplatin/carboplatin regimen having heterozygous genotype (AG) was associated with high mortality risk (p = 0.0001). 673 C>T polymorphism was associated with increased lung cancer risk. |